A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices

NCT00292409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia and Schizoaffective Disorder

Interventions

DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]